ICAM1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA002126

Antibody HPA004877

Antibody CAB002142

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Many tumors showed cytoplasmic and membranous immunoreactivity. Strongest staining was observed in renal cancers, prostate cancers and malignant lymphomas.Most malignant cells displayed moderate to strong cytoplasmic and membranous immunoreactivity. A majority of basal cell carcinomas, testicular, endometrial, prostate, breast and colorectal cancers were weakly stained or negative.Most malignant tissues were negative. Rare cases of squamous cell carcinoma, liver cancer and breast cancer showed moderate to strong cytoplasmic and membranous immunoreactivity.

Validation

Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected